# Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.

> **NCT06772272** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 158 (estimated)

## Conditions studied

- Perioperative Anemia

## Interventions

- **DRUG:** Roxadustat

## Key facts

- **NCT ID:** NCT06772272
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-10
- **Primary completion:** 2026-11-10
- **Final completion:** 2027-05-10
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06772272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06772272, "Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06772272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*